Market Place
Sourcing Support
Pfenex and NT Pharma Enter Dev &License Agreement for Pfenex`s PF708 to Forteo®
18 Apr 2018 //
PR NEWSWIRE
Forteo®(Teriparatide) : Eli Lilly And Company v. Apotex
04 Apr 2018 //
PATENT LITIGATION
FDA Denies Amneal Petition Seeking to Block Generic Versions of Osteoporosis
09 Jan 2018 //
RAPS
New Data on FORTEO® (teriparatide [rDNA origin] injection) Showed Reduced Risk
09 Nov 2017 //
PR NEWSWIRE
The Indian Peptides and Heparin Market Worth 883.0 Million & 170.2 Million
21 Aug 2017 //
PR NEWSWIRE
Gedeon Richter Plc Terrosa (teriparatide) Receives Approval In Europe
05 May 2017 //
EMA
Gedeon Richter Terrosa (Teriparatide) Receives Approval In Europe
16 Mar 2017 //
EMA
STADA Arzneimittel Movymia (Teriparatide) Receives Approval In Europe
16 Mar 2017 //
EMA
Glide raises £3.2m for solid dose injector programme
02 Feb 2017 //
PHARMATIMES
Nine Therapies Put Forward for EU Approval
15 Nov 2016 //
PHARMATIMES
Richter`s generic osteoporosis drug gets EU recommendation
14 Nov 2016 //
REUTERS
Amgen And UCB Present Data At ENDO 2016 Comparing Romosozumab With Teriparatide
01 Apr 2016 //
PR NEWSWIRE
Eli Lilly could see another 18 months of emerging markets slowdown
01 Feb 2016 //
FIERCE PHARMAASIA
Lilly falls short of analyst forecasts with 2016 guidance on the `weaker end`
05 Jan 2016 //
FIERCE PHARMA
Glide Announce Successful Proof-of-Concept With Novel Exenatide Formulation
05 Jan 2016 //
PR NEWS WIRE
Novozymes` Veltis extension technology embraced by Paras to develop biobetter
30 Nov 2015 //
CPHI-ONLINE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.